Cytokinetics, Incorporated · NASDAQ:CYTK

Henderson John T received 2,851 Cytokinetics, Incorporated shares as an award (Form 4)

Traded May 27, 2026 · Filed May 27, 2026

On May 27, 2026, Henderson John T (Director) received 2,851 Cytokinetics, Incorporated shares as an award, leaving 78,088 shares. Filed May 27, 2026 (Form 4).

Awarded
2,851 shares
Holding after
78,088 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 27, 2026Common StockAward2,85178,088Direct

Source

View original at SEC

Related